• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of tumor-targeted therapy using measles virus-displayed antibody library

Research Project

Project/Area Number 22659227
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeSingle-year Grants
Research Field General surgery
Research InstitutionThe University of Tokyo

Principal Investigator

NAKAMURA Takafumi  東京大学, 医科学研究所, 特任准教授 (70432911)

Project Period (FY) 2010 – 2011
Project Status Completed (Fiscal Year 2011)
Budget Amount *help
¥3,220,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥420,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2010: ¥1,400,000 (Direct Cost: ¥1,400,000)
Keywords実験外科学 / 癌 / ウイルス / 抗体 / バイオテクノロジー / 生体機能利用
Research Abstract

We have successfully developed a pseudoreceptor system which allows rescue and propagation of retargeted viruses displaying single chain antibody fragments(scFvs). Thus, receptor choice is not a significant limitation for targeting measles viruses and the use of single chain antibodies for targeting potentially allows us to redirect the virus against any chosen cellular receptor.
In this study, we try to develop measles virus-displayed scFv library(virobody library) using the technology for identification of tumor-specific scFv. Human A549 lung, or BxPC-3 pancreatic carcinoma cells were infected with virobody library at an MOI of 0. 01 to 1, one hour later the cells were washed with Opti-MEM medium(Invitrogen) four times. 2 to 5 days after infection, propagated viruses were harvested by repeated freeze-thaw cycles from the GFP-positive infected cells. The biopanning was repeated several times, and finally the tumor-targeted measles virus was cloned from the GFP-positive infected cells. The cDNA encoding scFv from the viral RNA genome was amplified by RT-PCR for sequence analysis. However, the identified scFvs were not functional as a tumor-specific antibody. We have assumed that the diversity of measles virus-displayed scFv library is not sufficient enough to identify tumor-specific scFvs. To address this question, not traditional ligation method but Gateway[○! R] Technology-based cloning method(Invitrogen) was used for generation of plasmid library. Various kind of scFvs were incorporated into the C terminus of a receptor-blind H gene in a full-length cDNA clone of Edmonston measles virus. Furthermore, infectious scFv-displaying measles viruses were rescued from the full-length cDNA clones using helper vaccinia virus expressing T7 RNA polymerase. These modifications dramatically increased the diversity of measles virus-displayed scFv library.

Report

(3 results)
  • 2011 Annual Research Report   Final Research Report ( PDF )
  • 2010 Annual Research Report
  • Research Products

    (23 results)

All 2012 2011 2010

All Journal Article (8 results) (of which Peer Reviewed: 6 results) Presentation (14 results) Patent(Industrial Property Rights) (1 results) (of which Overseas: 1 results)

  • [Journal Article] Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma2012

    • Author(s)
      Miyamoto S, Inoue H, Nakamura T, Yamada M, Sakamoto C, Urata Y, Okazaki T, Marumoto T, Takahashi A, Takayama K, Nakanishi Y, Shimizu H and Tani K.
    • Journal Title

      Cancer Res

      Volume: 72 Pages: 2609-2621

    • Related Report
      2011 Final Research Report
  • [Journal Article] Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties that Is Active Against Lung Adenocarcinoma2012

    • Author(s)
      Miyamoto S, Inoue H, Nakamura T, Yamada M, Sakamoto C, Urata Y, Okazaki T, Marumoto T, Takahashi A, Takayama K, Nakanishi Y, Shimizu H, Tani K
    • Journal Title

      Cancer Research

      Volume: (掲載確定)(印刷中) Issue: 10 Pages: 2609-2621

    • DOI

      10.1158/0008-5472.can-11-3185

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] MicroRNA regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor efficacy2011

    • Author(s)
      Hikichi M, Minoru Kidokoro M, Haraguchi T, Iba H, Shida H, Tahara H and Nakamura T
    • Journal Title

      Molecular Therapy

      Volume: 19 Pages: 1107-1115

    • Related Report
      2011 Final Research Report
  • [Journal Article] MicroRNA regulation of vaccinia virus for enhanced oncolytic activity and reduced pathogenicity in oncolytic virotherapy2011

    • Author(s)
      Hikichi M, Kidokoro M, Haraguchi T, Iba H, Shida H, Tahara H & Nakamura T.
    • Journal Title

      Molecular Therapy

      Volume: 19巻 Issue: 6 Pages: 1107-15

    • DOI

      10.1038/mt.2011.36

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] MicroRNA-based gene regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor efficacy2011

    • Author(s)
      Hikichi M, Minoru Kidokoro M, Haraguchi T, Iba H, Shida H, Tahara H, Nakamura T
    • Journal Title

      Molecular Therapy

      Volume: 19 Pages: 1107-1115

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] CD133 suppresses neuroblastoma cell differentiation via signal pathway modification2011

    • Author(s)
      Takenobu H, Shimozato O, Nakamura T, Ochiai H, Yamaguchi Y, Ohira M, Nakagawara A, Kamijo T
    • Journal Title

      Oncogene

      Volume: 30 Pages: 97-105

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer2010

    • Author(s)
      Katoh M, Kazuki Y, Kazuki K, Kajitani N, Takiguchi M, Nakayama Y, Nakamura T, Oshimura M
    • Journal Title

      BMC Biotechnology

      Volume: 10

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Enhanced Antitumor Effects of an Engineered Measles Virus Edmonston Strain Expressing the Wild-type N, P, L Genes on Human Renal Cell Carcinoma2010

    • Author(s)
      Meng X, Nakamura T, Okazaki T, Inoue H, Takahashi A, Miyamoto S, Sakaguchi G, Eto M, Naito S, Takeda M, Yanagi Y, Tani K
    • Journal Title

      Molecular Therapy

      Volume: 18 Pages: 544-551

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Presentation] MicroRNA Targeting of Oncolytic Viruses for cancer therapy2011

    • Author(s)
      Takafumi Nakamura.
    • Organizer
      第70回日本癌学会学術総会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-04
    • Related Report
      2011 Final Research Report
  • [Presentation] MicroRNA Targeting of Oncolytic Viruses for cancer therapy2011

    • Author(s)
      Nakamura T
    • Organizer
      第70回日本癌学会学術総会
    • Place of Presentation
      名古屋(名古屋国際会議場)
    • Year and Date
      2011-10-04
    • Related Report
      2011 Annual Research Report
  • [Presentation] MicroRNA Regulation of Glycoprotein B5R in Oncolytic Vaccinia Virus Reduces Viral Pathogenicity without Impairing its Antitumor Efficacy2011

    • Author(s)
      Mina Hikichi, Minoru Kidokoro, Hisatoshi Shida, Hideaki Tahara and Takafumi Nakamura.
    • Organizer
      The International Union of Microbiological Societies 2011 Congress
    • Place of Presentation
      札幌
    • Year and Date
      2011-09-12
    • Related Report
      2011 Final Research Report
  • [Presentation] MicroRNA Regulation of Glycoprotein B5R in Oncolytic Vaccinia Virus Reduces Viral Pathogenicity without Impairing its Antitumor Efficacy2011

    • Author(s)
      Nakamura T
    • Organizer
      The International Union of Microbiological Societies 2011 Congress
    • Place of Presentation
      札幌(札幌コンベンションセンター)
    • Year and Date
      2011-09-12
    • Related Report
      2011 Annual Research Report
  • [Presentation] Development of tumor-targeting vaccinia viruses as novel oncolytic agents2011

    • Author(s)
      Takafumi Nakamura, Mina Hikichi, Minoru Kidokoro, Hisatoshi Shida and Hideaki Tahara.
    • Organizer
      The 17th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      福岡
    • Year and Date
      2011-07-17
    • Related Report
      2011 Final Research Report
  • [Presentation] Development of tumor-targeting vaccinia viruses as novel oncolytic agents2011

    • Author(s)
      Nakamura T
    • Organizer
      The 17th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      福岡(九州大学医学部百年講堂)
    • Year and Date
      2011-07-17
    • Related Report
      2011 Annual Research Report
  • [Presentation] Enhancing therapeutic index of oncolytic vaccinia virus through combining micro RNA regulation and thymidine kinase deletion2011

    • Author(s)
      Mina Hikichi, Minoru Kidokoro, Hisatoshi Shida, Hideaki Tahara and Takafumi Nakamura.
    • Organizer
      The 14th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Seattle, USA
    • Year and Date
      2011-05-20
    • Related Report
      2011 Final Research Report
  • [Presentation] Enhancing therapeutic index of oncolytic vaccinia virus through combining microRNA regulation and thymidine kinase deletion2011

    • Author(s)
      Nakamura T
    • Organizer
      The 14th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Seattle, USA (Washington State Convention & Trade Center)
    • Year and Date
      2011-05-20
    • Related Report
      2011 Annual Research Report
  • [Presentation] MicroRNA Regulation of Oncolytic Vaccinia Virus Reduces Viral Pathogenicity without Impairing its Antitumor Efficacy2011

    • Author(s)
      Nakamura T
    • Organizer
      The 6th International Conference on Oncolytic Viruses As Cancer Therapeutics
    • Place of Presentation
      Las Vegas, U.S.A.(JW Marriott at Summerlin)
    • Year and Date
      2011-03-19
    • Related Report
      2010 Annual Research Report
  • [Presentation] 強い抗癌作用と高い安全性を兼ね備えたマイクロRNA制御増殖型ワクシニアウイルスによる癌ウイルス療法の開発2010

    • Author(s)
      中村貴史
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪(大阪国際会議場)
    • Year and Date
      2010-09-23
    • Related Report
      2010 Annual Research Report
  • [Presentation] マイクロRNAによって制御されるウイルスの開発とその応用2010

    • Author(s)
      中村貴史
    • Organizer
      第12回日本RNA学会年会
    • Place of Presentation
      東京(一橋記念講堂)
    • Year and Date
      2010-07-27
    • Related Report
      2010 Annual Research Report
  • [Presentation] MicroRNA-regulated oncolytic vaccinia virus not only enhances the oncolytic activity but also reduces the viral pathogenicity2010

    • Author(s)
      Nakamura T
    • Organizer
      The 16th Annual Meeting of Japan Society of Gene Therapy
    • Place of Presentation
      宇都宮(栃木県総合文化センター)
    • Year and Date
      2010-07-01
    • Related Report
      2010 Annual Research Report
  • [Presentation] Highly Attenuated Vaccinia Virus as a Potential Oncolytic Agent for Cancer Virotherapy2010

    • Author(s)
      Nakamura T
    • Organizer
      The 13th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Washington D.C., U.S.A.(Marriott Wardman Park Hotel)
    • Year and Date
      2010-05-22
    • Related Report
      2010 Annual Research Report
  • [Presentation] Highly attenuated vaccinia virus with microRNA-regulated oncolysis for cancer virotherapy2010

    • Author(s)
      Nakamura T
    • Organizer
      The 13th Annual Meeting of American Society of Gene & Cell Therapy
    • Place of Presentation
      Washington D.C., U.S.A.(Marriott Wardman Park Hote)
    • Year and Date
      2010-05-20
    • Related Report
      2010 Annual Research Report
  • [Patent(Industrial Property Rights)] マイクロRNA制御組換えワクシニアウイルス及びその使用2011

    • Inventor(s)
      中村貴史, 他4名
    • Industrial Property Rights Holder
      東京大学, 他2者
    • Filing Date
      2011-03-15
    • Related Report
      2010 Annual Research Report
    • Overseas

URL: 

Published: 2010-08-23   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi